Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relugolix vs leuprorelin acetate for adenomyosis with dysmenorrhea
jRCTs041240085Recruiting
- Start
- Jan 2025
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial in adenomyosis comparing Relugolix arm with Leuprorelin acetate arm (2 arms). Started Jan 2025; status: recruiting.
02
Drugs
tissue-plasminogen activatorleuprolide
03
Conditions
adenomyosis
Beyond the preview
Go deeper on jRCTs041240085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041240085.